Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xu Wang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Chaofu Wang

    Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    5 shared publications
  • Xuan Wang

    Department of Pathology, Ruijin Hospital and College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

    5 shared publications
  • Tuanjie Guo

    Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    4 shared publications
  • Siteng Chen

    Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Xiang Wang

    Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Xinchao Zhang

    Department of Pathology, College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications

Latest Publications

  • Open Access

    Microfluidic point-of-care testing for antimicrobial resistance: advances, strategies, and One Health perspectives

    by Chenxi Wang, Jun Feng, Chenjia Zhou, Leshan Xiu, Qinqin Hu, Hui Li, Xiaokui Guo, Xu Wang, Min Chen, Kun Yin


  • Open Access

    TGFβR Hyperactivation Drives CD103⁺/ITGB2⁺ TRM Cell Accumulation in High-Fat Diet-Exacerbated CIA

    by Sijia Yan, Jielin Sun, Khan Zara Ahmad, Xuan Wang, Lei Tong, Qiangdongzi Mao, Qingwen Wang, Adeleh Divsalar, Edwin Cheung, Chaofu Wang, et al.

    Obesity exacerbates rheumatoid arthritis (RA). However, the underlying mechanisms remain incompletely defined. Elucidating these mechanisms can help the identification of novel therapeutic targets. Herein, we used high-fat diet (HFD)-induced obese collagen-induced arthritis (CIA) mice to investigate these mechanisms. Immunohistochemistry revealed that obesity exacerbated joint inflammation and cartilage degradation. Next, integrated label-free quantitative proteomics and cytometry by time-of-flight (CyTOF) were used to characterize lymphocyte subsets. Proteomic profiling identified 26 differentially expressed proteins in obese versus lean CIA mice, including the transcription factors EOMES and KLF2, the TGFβ receptor (TGFβR) signaling component TGFBR2, and the tissue-resident memory (TRM) T cell marker CD103. CyTOF analysis revealed a robust 3.0-fold increase (P=0.0043) in the proportion of CD103⁺ TRM cells among CD3⁺ T cells in obese CIA mice, characterized by a large effect size. Immunofluorescence results confirmed this increase in synovial tissues. Treatment with asiaticoside (a TGF-β/Smad-suppressing triterpenoid) significantly reduced TRM cell proportions (P < 0.05) and ameliorated symptoms in obese CIA mice. Collectively, these findings establish a novel mechanistic axis in which obesity-induced TGFβR-hyperactivation promotes TRM cell accumulation, which exacerbates arthritis severity in this RA model. Our findings provide a preclinical rationale for targeting TGFβR/TRM in human RA with obesity as a comorbidity.

  • Open Access

    Advanced Immunoassays and Biosensing: From Design to Development

    by Dongyang Li, Xu Wang, Juan Pablo Salvador

    Over the past decade, the field of immunoassays and biosensing has undergone remarkable expansion, driven by the urgent demand for sensitive, rapid, and reliable detection technologies across biomedical, environmental, and food safety applications

  • Open Access

    SCGN recruits macrophages by regulating chemokine secretion in clear cell renal cell carcinoma

    by Tuanjie Guo, Xinchao Zhang, Xuan Wang, Heting Tang, Yang Liu, Siteng Chen, Zhengchuan Niu, Chaofu Wang, Xu Wang, Xiang Wang

    Immunotherapy is considered to be one of the most promising curative modalities for cancer, and the effectiveness of immunotherapy depends on the abundance of immune cells in the tumor microenvironment (TME). Immunotherapy tends to be more effective in “hot tumors” characterized by a high abundant immune cells. Our previous studies found that secretagogin (SCGN) showed intranuclear aggregation in the early stages of clear cell renal cell carcinoma (ccRCC) development. However, with tumor progression and distant metastasis of the ccRCC, the expression of SCGN is gradually absent. In this study, we found that SCGN did not affect the malignant phenotype of cancer cells, but could regulate cytokine/chemokine secretion and immune cell migration by performing gene function assays and RNA-seq analyses after overexpressing SCGN in cell lines of ccRCC. Bioinformatics analysis, Transwell and co-culture experiments confirmed that ccRCC cells overexpressing SCGN could recruit M1-type macrophages. Mechanistically, SCGN initiates downstream cytokine/chemokine expression and secretion through the NF-κB signal pathway. This study provides a comprehensive understanding of the function of SCGN in ccRCC. Continuous forced expression of SCGN at different stages may be a potential approach for the treatment of ccRCC.


  • ALK-positive large B-cell lymphoma: a clinicopathological and molecular characteristics analysis of seven cases

    by Xuan Wang, Hongmei Yi, Qingxiao Liu, Tuanjie Guo, Anqi Li, Binshen Ouyang, Yimin Li, Yuxiu Zhang, Haimin Xu, Lei Dong, et al.


  • Open Access

    Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progression

    by Tuanjie Guo, Xuan Wang, Tao Wang, Jian Zhang, Yang Liu, Siteng Chen, Xu Wang, Xiaoqun Yang, Chaofu Wang, Xiang Wang

    The secretagogin (SCGN) was originally identified as a secreted calcium-binding protein present in the cytoplasm. Recent studies have found that SCGN has a close relationship with cancer. However, its role in the occurrence, progression, and prognosis of clear cell renal cell carcinoma (ccRCC) remains unclear. In this study, we utilized a mutual authentication method based on public databases and clinical samples to determine the role of SCGN in the progression and prognosis of ccRCC. Firstly, we comprehensively analyzed the expression characteristics of SCGN in ccRCC in several public databases. Subsequently, we systematically evaluated SCGN expression on 252 microarrays of ccRCC tissues from different grades. It was found that SCGN was absent in all the normal kidney tissues and significantly overexpressed in ccRCC tumor tissues. In addition, the expression level of SCGN gradually decreased with an increase in tumor grade, and the percentage of SCGN staining positivity over 50% was 86.7% (13/15) and 73.4% (58/79) in Grade1 and Grade2, respectively, while it was only 8.3% (12/144) in Grade3, and the expression of SCGN was completely absent in Grade4 (0/14) and distant metastasis group (0/4). Additionally, the expression of SCGN was strongly correlated with the patient's prognosis, with the higher the expression levels of SCGN being associated with longer overall survival and disease-free survival of patients. In conclusion, our results suggest that reduced expression of SCGN in cancer cells is correlated with the progression and prognosis of ccRCC.


  • Open Access

    Predicting early gastric cancer risk using machine learning: A population-based retrospective study

    by Xing Ke, Xinyu Cai, Bingxian Bian, Yuanheng Shen, Yunlan Zhou, Wei Liu, Xu Wang, Lisong Shen, Junyao Yang

    Background: Early detection and treatment are crucial for reducing gastrointestinal tumour-related mortality. The diagnostic efficiency of the most commonly used diagnostic markers for gastric cancer (GC) is not very high. A single laboratory test cannot meet the requirements of early screening, and machine learning methods are needed to aid the early diagnosis of GC by combining multiple indicators. Methods: Based on the XGBoost algorithm, a new model was developed to distinguish between GC and precancerous lesions in newly admitted patients between 2018 and 2023 using multiple laboratory tests. We evaluated the ability of the prediction score derived from this model to predict early GC. In addition, we investigated the efficacy of the model in correctly screening for GC given negative protein tumour marker results. Results: The XHGC20 model constructed using the XGBoost algorithm could distinguish GC from precancerous disease well (area under the receiver operating characteristic curve [AUC] = 0.901), with a sensitivity, specificity and cut-off value of 0.830, 0.806 and 0.265, respectively. The prediction score was very effective in the diagnosis of early GC. When the cut-off value was 0.27, and the AUC was 0.888, the sensitivity and specificity were 0.797 and 0.807, respectively. The model was also effective at evaluating GC given negative conventional markers (AUC = 0.970), with the sensitivity and specificity of 0.941 and 0.906, respectively, which helped to reduce the rate of missed diagnoses. Conclusions: The XHGC20 model established by the XGBoost algorithm integrates information from 20 clinical laboratory tests and can aid in the early screening of GC, providing a useful new method for auxiliary laboratory diagnosis.


  • Top Cited Papers
    Open Access

    TET (Ten-eleven translocation) family proteins: structure, biological functions and applications

    by Xinchao Zhang, Yue Zhang, Chaofu Wang, Xu Wang

    Ten-eleven translocation (TET) family proteins (TETs), specifically, TET1, TET2 and TET3, can modify DNA by oxidizing 5-methylcytosine (5mC) iteratively to yield 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxycytosine (5caC), and then two of these intermediates (5fC and 5caC) can be excised and return to unmethylated cytosines by thymine-DNA glycosylase (TDG)-mediated base excision repair. Because DNA methylation and demethylation play an important role in numerous biological processes, including zygote formation, embryogenesis, spatial learning and immune homeostasis, the regulation of TETs functions is complicated, and dysregulation of their functions is implicated in many diseases such as myeloid malignancies. In addition, recent studies have demonstrated that TET2 is able to catalyze the hydroxymethylation of RNA to perform post-transcriptional regulation. Notably, catalytic-independent functions of TETs in certain biological contexts have been identified, further highlighting their multifunctional roles. Interestingly, by reactivating the expression of selected target genes, accumulated evidences support the potential therapeutic use of TETs-based DNA methylation editing tools in disorders associated with epigenetic silencing. In this review, we summarize recent key findings in TETs functions, activity regulators at various levels, technological advances in the detection of 5hmC, the main TETs oxidative product, and TETs emerging applications in epigenetic editing. Furthermore, we discuss existing challenges and future directions in this field.